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Abstract
Background: Dental caries is a persistent public health problem with little change in the prevalence in young
children over the last 20 years. Once a child contracts the disease it has a significant impact on their quality of life.
There is good evidence from Cochrane reviews including trials that fluoride varnish and regular use of fluoride
toothpaste can prevent caries.
The Northern Ireland Caries Prevention in Practice Trial (NIC-PIP) trial will compare the costs and effects of a caries
preventive package (fluoride varnish, toothpaste, toothbrush and standardised dental health education) with dental
health education alone in young children.
Methods/Design: A randomised controlled trial on children initially aged 2 and 3 years old who are regular
attenders at the primary dental care services in Northern Ireland. Children will be recruited and randomised in
dental practices. Children will be randomised to the prevention package of both fluoride varnish (twice per year for
three years), fluoride toothpaste (1,450 ppm F) (supplied twice per year), a toothbrush (supplied twice a year) or
not; both test and control groups receive standardised dental health education delivered by the dentist twice per
year. Randomisation will be conducted by the Belfast Trust Clinical Research Support Centre ([CRSC] a Clinical Trials
Unit).
1200 participants will be recruited from approximately 40 dental practices. Children will be examined for caries by
independent dental examiners at baseline and will be excluded if they have caries. The independent dental
examiners will examine the children again at 3 years blinded to study group.
The primary end-point is whether the child develops caries (cavitation into dentine) or not over the three years.
One secondary outcome is the number of carious surfaces in the primary dentition in children who experience
caries. Other secondary outcomes are episodes of pain, extraction of primary teeth, other adverse events and costs
which will be obtained from parental questionnaires.
Discussion: This is a pragmatic trial conducted in general dental practice. It tests a composite caries prevention
intervention, which represents an evidence based approach advocated by current guidance from the English
Department of Health which is feasible to deliver to all low risk (caries free) children in general dental practice. The
trial will provide valuable information to policy makers and clinicians on the costs and effects of caries prevention
delivered to young children in general dental practice.
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Background
Although dental caries is a preventable disease it is a
persistent public health problem, with little change in
t h ep r e v a l e n c ei ny o u n gc h i l d r e no v e rt h el a s t2 0
years [1]. Caries is closely associated with social depriva-
tion resulting in large geographical and social inequal-
ities across the UK. The last national child dental health
survey [1] showed that in 2003 43% and 61% of 5-year-
olds in England and Northern Ireland respectively had
caries; 10 years earlier, the figures were 45% and 60%.
Over the last 10 years the proportion of parents taking
children under 3 years to the dentist increased from
42% to 54% [1]; evidently this favourable change in visit-
ing patterns has not been translated into reduced levels
of tooth decay in the population.
Few prospective studies have been undertaken to pro-
vide an understanding of how the disease behaves longi-
tudinally [2] A recently completed prospective cohort
study [2,3] followed 739 children aged 3 to 6 years
attending 50 dental practices in the North West of Eng-
land over a 3 year period. This study demonstrated a
stark difference between children who present with and
without the disease at their first visit to the dentist.
Over the study period 25% of caries free children devel-
oped caries, by contrast 72% of those with the disease at
initial presentation developed further cavities. No matter
what age a child contracted the disease it progressed at
the same rapid rate. An important finding of this study
was that more cases (children with caries) arose from
the initially caries free population (N = 155, 21% of the
total population and 25% of the population who were
caries free at first attendance) than from those who pre-
sent with the disease at their first visit to the dentist (N
= 118, 16%). NHS Business Services Organisation (BSO)
data shows that this situation is mirrored in Northern
Ireland; 25% of 2-3-year-old children have the disease at
initial presentation but 35% who are caries free at their
first visit go on to develop the disease over a 3 year per-
iod. Once a child contracts the disease there is a signifi-
cant impact on their quality of life and that of their
family. Children with caries have an 18.8% chance each
year of an unscheduled visit due to toothache and an
11% chance of an extraction each year [4]. As adverse
outcomes are so common in children with the disease,
the priority should be prevention, with a primary focus
of maintaining the caries free children in that state.
Dentists cannot prevent the disease starting in children
who already have caries at their first visit; these children
should be considered as a separate population; their
dental care needs are quite different and are compli-
cated by the effects of restorative treatment.
The need to improve preventive care provided by den-
tists has moved up the policy agenda following the pub-
lication of the Primary Dental Care Strategy for
Northern Ireland [5] in 2006, which placed a strong
emphasis on prevention of caries in general practice,
and the subsequent Oral Health Strategy for Northern
Ireland in 2007 [6], which sets targets for reduction in
the caries levels of 5-year-olds. The introduction of new,
locally commissioned NHS dental contracts in England
and Wales in April 2006 also means that strengthening
the evidence base for prevention is important for policy
makers and the NHS. One of the main reasons for
changing NHS dental contracts was to encourage pre-
vention, however the new contract in England has been
heavily criticised by the dental profession and NHS
managers [7] and more recently by the House of Com-
mons Health Select Committee [8] for offering little
incentive for dentists to provide preventive care. Indeed
one of the recommendations of the Health Select Com-
mittee report was that ‘the Department of Health under-
take research to determine the extent to which the
provision of preventive advice is being given and its
cost-effectiveness.’ This emphasis on prevention is also
seen in the Darzi report [9] and the Primary and Com-
munity Care Strategy [10]. Scotland has decided to
retain the centrally funded GDS contract based on capi-
tation for children and fee for item for adults. The
Department of Health in Northern Ireland intends to
change the GDS contract and wants to use the out-
comes of this trial to inform preventive aspects of the
new contract. So, there is pressure on politicians, policy
makers and NHS commissioners in the UK to ensure
that effective caries preventi o ni sp r o v i d e di np r a c t i c e .
Unfortunately recent research suggests that the preven-
tive care currently provided by GDPs is ineffective and
inequitable [11]. Dentists are ill-equipped in terms of
their knowledge [12] and how they present information
to their patients [13] to provide an effective service.
Preventive care provided by most dentists is based on
health education aimed at reducing sugar intake [12,13]
which lacks evidence to demonstrate its effectiveness
[14,15]. However, there is good evidence that fluoride-
based interventions can have a dramatic effect on the
disease. For example in a systematic review of water
fluoridation [16] the median of mean differences of
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Page 2 of 9studies suggested that a 15% absolute difference in the
proportions of children caries free can be expected
between fluoridated and non-fluoridated populations. It
has been estimated that this equates to a difference of
around 40% in caries increment [17]. In England water
fluoridation is currently being examined as a means of
preventing caries but is not technically, economically or
politically feasible in every area of the UK, so other
delivery vehicles such as professionally applied fluoride
varnish or distributed fluoride toothpaste need to be
considered. A Cochrane systematic review of fluoride
v a r n i s h[ 1 8 ]i n c l u d e d9R C T sa n dr e p o r t e dap o o l e dd
(e/m)fs prevented fraction estimate of 33% (95% CI, 19%
to 48%; p < 0.0001). A second systematic review [19] of
fluoride varnish used different selection criteria and
identified only 3 trials examining primary teeth and con-
cluded that the evidence was inconclusive due to the
poor quality of the studies. A subsequently published
trial of 2-4 year old children [20] examined the effect of
22,600 ppm varnish applied twice a year over 2 years
and reported a 57% reduction in caries increment com-
pared to a control group. Another recent trial in the
USA [21] investigated the use of 22,600 ppm varnish on
infants with a mean age of 1.8 years resident in an area
supplied with artificially fluoridated water at 1 ppm.
Caries incidence was lower in those receiving fluoride
varnish twice a year than in a counselling only control
(OR 3.77 (95% CI 1.88-7.58) and no adverse events were
reported.
A Cochrane review of fluoride toothpaste use [22] in
children aged 5-16 years reported clear evidence that
fluoride toothpastes are efficacious in preventing caries
in permanent teeth but there was little information con-
cerning the primary dentition or adverse effects. Similar
findings were also reported by another systematic review
of toothpastes published around the same time[23]. An
RCT in the North West [24] testing fluoride toothpaste
provided through the post to children from birth to 5-
years-old reported a 16% difference in increment and an
8% absolute difference in the proportion of caries free
children receiving 1450 ppm toothpaste compared to a
control group. A Cochrane systematic review examined
the effectiveness of any fluoride agent (gel, varnish,
mouth rinse) combined with toothpaste [25] and
reported a D(M)FS pooled preventive fraction of 10%
(95% CI, 2% to 17%; p = 0.01) in favour of a combined
regimen over toothpaste alone but the significant differ-
ence in favour of the combined use of fluoride varnish
and toothpaste accrued from a very small trial and
appears likely to be a spurious result. The risks asso-
ciated with these two interventions are small for the age
group under investigation. A follow up study [26] of
participants in the NW toothpaste trial [24] compared
the prevalence of fluorosis in the study groups and
reported a slight increase in prevalence of TF score 3
(an index of fluorosis) but no increase in the overall pre-
valence of developmental defects of enamel. Recent
work shows that fluorosis risk is related to an elevated
fluoride intake for all of the first 3 years of life [27] but
that the first 2 years of life are the period with greatest
risk [28].
Although sub-optimal, the available literature has
informed the contents of Delivering Better Oral Health
an Evidence Based Toolkit [29] national guidance that
has been circulated by the Department of Health to
every dental practice in England. The fluoride interven-
tions to be investigated in this trial are identified by the
Toolkit and the approach taken in this trial; focusing on
caries free children is also supported by the Toolkit,
which recommends application of the interventions to
all children attending dental practice, the majority of
whom will be caries free at their first attendance. This
reasoning was informed by the outcomes of the North
West cohort study [7] and because there are no effective
screening tools to accurately and reliable identify the
children who will develop caries. The effectiveness of
the intervention to be tested and the impact on NHS
costs are unknown and need to be tested in primary
care.
The aim of this study is to therefore measure the costs
and effects of a ‘preventive package’ of fluoride varnish,
fluoride toothpaste, toothbrush and standard dental
health education in keeping young children who regu-
larly attend primary care service free of dental caries,
compared with receiving standard dental health educa-
tion alone.
If the technologies tested in this trial are effective at
preventing caries and reducing costs it will influence
how dentistry is provided for young children both in the
UK and internationally. If the interventions are shown
not to be an efficient use of resources this will also
influence policy and commissioning, to perhaps focus
prevention resources on population interventions such
as water fluoridation.
Methods/Design
Trial Objectives
To compare over a 3 year period the effectiveness of
fluoride varnish, fluoride toothpaste, toothbrush and
standardised health education, provided twice a year, as
a preventive package, with standardised health education
alone provided twice a year in preventing the conversion
of 2 to 3 year old children from caries-free at baseline to
caries-active state in the primary dentition, reducing the
number of carious surfaces (caries into dentine) in the
primary dentition in children who convert from caries
free to caries active states and preventing episodes of
pain and extraction of primary teeth.
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care in a group receiving fluoride varnish, fluoride
toothpaste, toothbrush and standardised health educa-
tion, provided twice a year as a preventive package with
a group receiving standardised health education alone
provided twice a year.
Study design
NIC-PIP is a pragmatic three year parallel group rando-
mised controlled trial where 2 and 3 year old children
are randomised to receive the caries preventive package
or not. The recruitment of the children is outlined in
Figure 1. A full economic evaluation of the costs of the
package is being conducted.
Ethical considerations
Full ethical approval for this study has been obtained
from Northwest 7 REC- GM Central (formally Central
Manchester Research Ethics Committee). Two external
bodies; a Data Monitoring and a Trial Steering Commit-
tee, will monitor study progress.
Study Participants
Participants will be children who are initially aged 2 and
3.99 years who attend NHS General Dental Service
(GDS) practices in Northern Ireland. Children will be
eligible to participate in the study if they are aged 2 or 3
years, attending the selected GDS practices and a person
with parental responsibility signs a consent form. The
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Figure 1 Trial schematic showing the screening, recruitment and randomisation of children.
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tine, a past history of fillings or extractions due to car-
ies, fissure sealants on primary molar teeth, history of
severe allergic reactions requiring hospitalisation or are
already participating in any other clinical trial involving
medical products at recruitment.
Trial interventions
The fluoride varnish (22,600 ppm) is classed as an
Investigative Medicinal Product and therefore must
comply with relevant UK regulations [30]. The fluoride
varnish and toothpaste will appear in its normal com-
mercial packaging. The fluoride varnish will be applied
to the dried primary teeth of the children by a partici-
pating dentist at two visits to the dental surgery each
year at approximately 6 monthly intervals (+/- 4 weeks).
One drop of varnish will be applied to the primary teeth
in each arch (2 drops in total) using a standardised
brush applicator. After application parents will be
advised not to brush their children’s teeth for 24 hours.
A free toothbrush and a free 50 ml tube of 1,450 ppm
of fluoride toothpaste will also be provided to test group
children twice a year. Parents of children aged 2 but not
3 years will be advised to use a smear of toothpaste and
those over 3 years will be advised to use a pea sized
blob of toothpaste when brushing their teeth. Photo-
graphs of a smear and a pea size blob will be included
in the standardised dental health education guide. It will
be stressed to parents that children must be supervised
by an adult when they brush their teeth. Standardised
dental health education will be given at each 6 month
check up visit by dentists following written guidance.
Children allocated to the control group will attend at
6 monthly intervals and receive the same standardised
dental health education at each 6 month visit as the test
group. The control group will not receive any profes-
sionally applied or provided fluoride interventions.
Follow-up of children
Children will be followed from trial entry until the end
of the study (three years). They will attend the dentist
every 6 months where data on any symptoms reported
or treatment received by each child at each visit (both
planned 6 monthly and unplanned symptomatic visits)
will be collected on site clinical record forms. A piloted
questionnaire for the person with parental responsibility
will be used to identify any unscheduled visits to other
dental services and other episodes of toothache not
severe enough to require a visit to the dentist. Fluoride
varnish has been used routinely in dental practice and
the risk to participants is low. The reporting criteria for
adverse events is shown in Figure 2. The trial manager
is undertaking duties delegated by the trial sponsor and
is responsible for reporting of Suspected Unexpected
Serious Adverse Reactions (SUSARs) and other Serious
Adverse Reactions (SARs) to the competent authorities
(regulatory authorities and central research ethics com-
mittees). The person with parental responsibility, and
children, where appropriate, have the right to withdraw
from the trial at any time for any reason, and this will
be documented.
Outcome measures
Baseline and outcome examinations at 3 years will be
performed by trained and calibrated examiners. Out-
come examiners will be blinded to the treatment alloca-
t i o na n du s i n gt h es a m ed i a g n o s t i cp r o t o c o l .T h e
primary outcome is to measure whether the child has
become caries active (caries into dentine). The following
secondary outcomes are to be measured on the children:
the number of carious surfaces (caries into dentine) in
the primary dentition for children who have become
caries active, the number of episodes of pain and num-
ber of extractions of primary teeth and the costs of den-
tal care over a 3 year period. The final three outcomes
will be assessed by questionnaire filled in by the person
with parental responsibility.
Randomisation
Potentially eligible children will be identified from the
electronic databases of practices or in the case of prac-
tices without a computer by the Business Services Orga-
nisation. These children will be block-booked into
dedicated trial sessions in the dental practices. A sepa-
rate randomisation schedule will be prepared by the
CRSC for each recruiting centre using randomised per-
mutated blocks. The block lengths will vary to ensure
the centres are blind to patient allocation. An invitation
letter and trial information leaflet will be sent to parents
of identified children asking if they would like to partici-
pate in the trial. An appointment for a check-up will be
included in the invitation and will stress that the adult
with parental responsibility for the child must accom-
pany the child when they attend for assessment. The
child’s dentist or the external dental examiners (who
will undertake the baseline examinations) will consent
the children into the trial. Baseline assessment will be
undertaken after each child has been consented but
prior to randomisation.
An eligibility form will be faxed to the CRSC, where
the children will be centrally randomised to one of the
two treatment groups. The children will initially be
identified at registration by their initials, date of birth
and gender only. Once all of the eligibility criteria have
been verified by the CTU they will provide the investi-
gator with confirmation of the treatment allocation via
fax to provide a paper record of the allocation, and the
unique patient ID will be assigned.
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The principal outcome measure is whether the child
develops caries in the primary dentition or not. We
expect to see an absolute difference in the proportion of
children with caries after 3 years of 0.1 between test and
control groups. If caries free children are selected for
the study it is estimated that 47% will develop caries
over the three years. A two group chi-square test with a
0.050 two-sided significance level will have 90% power
to detect the difference between a proportion of 0.470
 
 
 
 
 
   
 
Was the SAE specified in the protocol as exempt from reporting on the SAE form? e.g. 
Was the event serious? 
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2  Life-threatening 
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Figure 2 Flow chart of assessing and notification of Adverse Events.
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Page 6 of 9and a proportion of 0.370 (odds ratio of 0.662) when the
sample size in each group is 510. We assume that 2%
will be excluded because of a history of severe allergic
reaction and a further 1% for other reasons. We also
assume that 75% of children approached will be caries
free and a 70% consent rate with an estimated 15%
drop-out rate over the 3 years. Therefore we will need
to initially invite at least 2,356 children to take part in
the study, recruiting 1200 children to ensure we have
sufficient power at the end of the trial. The recruitment
process is summarised in the CONSORT flow chart in
Figure 3.
       
 
 
 
 
 
 
 
 
Assessed for eligibility 
(n= 2356) 
Excluded (2%, n=47) history of 
hospitalization to allergic reaction 
 
Not meeting inclusion criteria due to 
presence of caries (25% of 2309, 
n=577) 
 
Refused to consent (30% of 1732, 
n=520) 
 
Other reasons (1% of 1212, n= 12) 
Analyzed  (n= 510) 
 
Excluded from analysis  (n= 0) 
Give reasons – we will include all 
participants in the analysis 
Lost to follow-up  (14%, n=84) 
Give reasons – Left practice, moved 
from area 
Discontinued intervention (1%, n=6) 
Give reasons – Dislike fluoride varnish 
intervention and concerns about 
effectiveness of intervention 
Allocated to test group (n= 600) 
Received allocated intervention – 
preventive package fluoride varnish and 
fluoride toothpaste plus standardized 
health education  (n= 600) 
Did not receive allocated intervention 
(n= 0) 
 
Lost to follow-up   (14%, n= 84) 
Give reasons – Left practice, moved 
from area 
Discontinued intervention (1% n=6) 
Give reasons – concerns about 
possible caries development  
Allocated to control group (n= 600) 
Received allocated intervention-
standardized health education only (n= 
600) 
Did not receive allocated intervention 
(n= 0) 
 
Analyzed  (n= 510) 
 
Excluded from analysis  (n= 0 ) 
Give reasons – we will include all 
participants in the analysis 
Allocation 
Analysis 
Follow-Up 
Enrolment 
Randomization 
Figure 3 CONSORT flowchart showing the estimated numbers of children throughout the trial.
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All analyses will use an ‘intention to treat’ principal. All
outcome measures stated in the protocol will be fully
analysed using generalized linear models adjusting for
covariates felt to be of prognostic importance including
age and socio-economic status (SES). Statistical signifi-
cance will be at the 0.05 level for all analysis and 95%
confidence intervals will be calculated. A binary logistic
regression model will be fitted to the primary outcome,
whether the child remained caries free or not, with
study group, age and socioeconomic status as covariates.
The unadjusted and adjusted odds ratios from the logis-
tic regression model will be reported and will specify
that the adjusted is the primary analytical approach. A
pre-planned subgroup analysis will be undertaken for
deprived/not deprived children by selecting children
whose parents are exempt from dental charges or not.
Health economic analysis will compare the total cost
to the NHS for dental care in each of the two arms of
the trial in accordance with the relative levels of effec-
tiveness for each of the two arms. A multiple linear
regression model will be fitted to the individual dis-
counted costs per child with group, age and socio-eco-
nomic status (SES) as covariates. If the assumptions
underlying the model are not upheld, robust estimates
of the standard errors will be calculated for the esti-
mated parameters. Separate calculations will be made
of between-treatment differences in cost to parents to
identify any between-programme trade-offs. All calcu-
lations will be subjected to sensitivity analysis and dis-
count rates of 3.5% for both cost and benefits will be
applied. The incremental cost effectiveness ratio
(ICER) will be estimated by dividing the difference in
mean discounted costs between the two groups by the
difference in discounted proportions that remain caries
free. The relationship between cost and secondary out-
comes such as the number of carious surfaces will be
examined in an analogous fashion to that detailed
above. The net present value of costs will be divided
by the net present value of the number of carious sur-
faces to ascertain the average cost for carious surface
avoided.
Time plan for the NIC-PIP study
Patient recruitment began in April 2011 and is planned
to continue until November 2011.
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